Position in BMY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,739,490
-$270,996 QoQ
Shares Held
30,189
-8.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#897
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caldwell Trust Co holds $66,282,067 across 15 Drug Manufacturers - General names. BMY ranks #6 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,550 | $25,847,718 | |
| 2 | JNJ |
Johnson & Johnson
|
56,485 | $14,345,495 | |
| 3 | AMGN |
Amgen Inc
|
26,584 | $9,626,598 | |
| 4 | ABBV |
AbbVie Inc.
|
27,070 | $6,811,894 | |
| 5 | MRK |
Merck & Co., Inc.
|
35,474 | $4,558,408 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
30,189 | $1,739,490 | |
| 7 | AZN |
Astrazeneca PLC
|
8,454 | $1,603,047 | |
| 8 | PFE |
Pfizer Inc
|
44,139 | $1,062,867 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,739,490 | 30,189 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,010,486 | 33,149 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,811,520 | 33,584 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $1,586,212 | 35,171 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,695,556 | 36,629 | Shares | Sole | 2025-09-22 | |
| 2025-03-31 | $2,307,739 | 37,838 | Shares | Sole | 2025-09-23 | |
| 2024-12-31 | $2,132,481 | 37,703 | Shares | Sole | 2025-09-24 | |
| 2024-09-30 | $2,016,152 | 38,967 | Shares | Sole | 2025-09-24 | |
| 2024-06-30 | $1,677,728 | 40,398 | Shares | Sole | 2025-09-24 | |
| 2024-03-31 | $2,230,913 | 41,138 | Shares | Sole | 2025-09-24 | |
| 2023-12-31 | $2,224,288 | 43,350 | Shares | Sole | 2025-10-01 | |
| 2023-09-30 | $2,681,041 | 46,193 | Shares | Sole | 2025-10-01 | |
| 2023-06-30 | $3,135,724 | 49,034 | Shares | Sole | 2025-10-01 | |
| 2023-03-31 | $3,480,470 | 50,216 | Shares | Sole | 2025-10-01 | |
| 2022-12-31 | $3,696,359 | 51,374 | Shares | Sole | 2025-10-01 | |
| 2022-09-30 | $3,625,021 | 50,992 | Shares | Sole | 2025-10-01 | |
| 2022-06-30 | $4,019,477 | 52,201 | Shares | Sole | 2025-10-02 | |
| 2022-03-31 | $3,554,297 | 48,669 | Shares | Sole | 2025-10-02 | |
| 2021-12-31 | $3,070,550 | 49,247 | Shares | Sole | 2025-10-02 | |
| 2021-09-30 | $2,970,156 | 50,197 | Shares | Sole | 2025-10-02 | |
| 2021-06-30 | $3,552,084 | 53,159 | Shares | Sole | 2025-10-02 | |
| 2021-03-31 | $3,438,375 | 54,465 | Shares | Sole | 2025-10-02 | |
| 2020-12-31 | $3,413,324 | 55,027 | Shares | Sole | 2025-10-02 | |
| 2020-09-30 | $3,703,795 | 61,433 | Shares | Sole | 2025-10-02 | |
| 2020-06-30 | $3,865,982 | 65,748 | Shares | Sole | 2025-10-02 | |
| 2020-03-31 | $3,664,124 | 65,736 | Shares | Sole | 2025-10-02 | |
| No filing history on record for this holder in this stock. | ||||||